http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111110926-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-047 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-04 |
| filingDate | 2020-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111110926-B |
| titleOfInvention | Injectable colored gel pad for alimentary canal mucosa layering and application thereof |
| abstract | The invention relates to the field of biomedical engineering, and discloses an injectable colored gel pad for gastrointestinal mucosa layering and application thereof. The silk fibroin solution, the chitosan solution or the gelatin solution is firstly injected into the submucosa of the alimentary canal, then the genipin solution containing the disodium glycerophosphate is injected, and a gel pad is formed at the submucosa of the alimentary canal after the cross-linking reaction, is used for separating the pathological mucosa layer from the muscle layer, and is convenient for stripping the pathological mucosa layer. The invention can control the formation time of the gel pad by controlling the dosage of the genipin and the disodium glycerophosphate in the genipin solution. The materials adopted in the invention are all liquid materials with low cytotoxicity and high biocompatibility, and the formed gel pad is dark blue, so that pathological tissues can be clearly marked, the mucosa stripping operation is more convenient and safer, and the gel pad has a good clinical use effect and is worthy of clinical popularization. |
| priorityDate | 2020-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.